Publications by authors named "A M Prudenzano"
Sustained Efficacy, Safety and High Adherence Rate of Onabotulinum Toxin Type A in Chronic Migraine Patients: A Multicentric Prospective Real-Life Study.
Toxins (Basel)
December 2022
Article Synopsis
- There is a lack of guidelines on the long-term use of onabotulinumtoxinA (onaBT-A) for chronic migraine prevention.
- In a study with 195 patients treated over 5 cycles, about 52.3% were classified as "responders," highlighting the efficacy of the treatment.
- The study found that most patients maintained improvement, experienced mostly mild side effects, and showed good adherence to ongoing treatment compared to traditional oral medications.
Background: A novel coronavirus (SARS-CoV-2)-induced pneumonia (COVID-19) emerged in December 2019 in China, spreading worldwide. The aim of the present investigation was to evaluate the immunological response and the clinical subset of peripheral lymphocyte subset alteration in COVID-19 infection.
Methods: the study was conducted on four different clinical groups ( = 4; total = 138).
Objectives: The study aims to assess the impact of the second COVID-19 pandemic wave on migraine characteristics.
Methods: This is an observational cross-sectional study conducted on migraine patients previously interviewed during the first Italian pandemic outbreak. A second structured telephone interview was conducted between 20 November 2020 and 18 January 2021.
The coronavirus disease 2019 (COVID-19) pandemic is a worldwide medical challenge due to the scarcity of proper information and remedial resources. The ability to efficiently avoid a further SARS-CoV-2 pandemic will, therefore, depend on understanding several factors which include host immunity, virus behavior, prevention measures, and new therapies. This is a multi-phase observatory study conducted in the SG Moscati Hospital of Taranto in Italy that was converted into COVID-19 Special Care Unit for SARS-Co-V2 risk management.
View Article and Find Full Text PDFPrevious studies during SARS and Ebola pandemics have shown that quarantine is associated with several negative psychological effects, such as post-traumatic stress symptoms, confusion, and anger. These conditions may affect the course of many diseases, including migraine. Although it is possible that the quarantine measures for the current COVID-19 pandemic affect migraine burden, no information is currently available on this issue.
View Article and Find Full Text PDF